MedPlus IPO description – The company was founded in 2006 by Gangadi Madhukar Reddy and now it’s second largest pharmacy retailer in India, in terms of revenue and number of stores as of 31 March 2021. The company’s products range includes (i) pharmaceutical and wellness products, including medicines, vitamins, medical devices and test kits, and (ii) fast-moving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers.
The company has a retail network of over 2,000 stores distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal and Maharashtra, as of 31 March 2021. Its share of the organized pharmacy retail market, based on revenue from operations, in Chennai, Bangalore, Hyderabad and Kolkata stood at approximately 30%, 29%, 30% and 22%, respectively in FY2021.
For FY2021, its average revenue per store was approximately INR15.9 million, as compared to the average revenue per store in the domestic pharmacy retail industry of approximately INR2.3 million.
As of 30 September 2021, its mature stores had a median payback period of less than 3 years and demonstrated a compounded average same store sales growth of 8.3% on MRP from FY2019 to FY2021. For the FY2021 and the six months ended 30 September 2021, its Store Level Operating EBITDA Margin for mature stores was 11.0% and 11.58%, respectively, and its Store Level Operating ROCE for Mature Stores for the financial year 2021 was over 60%.
Promoters of MedPlus Health– Gangadi Madhukar Reddy, Lone Furrow Investments Private Limited and Agilemed Investments Private Limited
MedPlus IPO Details
Subscription Dates | 13 – 15 December 2021 |
Price Band | INR780 – 796 per share (employee discount – INR78 per share) |
Fresh issue | INR600 crore |
Offer For Sale | INR798.3 crore |
Total IPO size | INR1,398.3 crore |
Minimum bid (lot size) | 18 shares |
Face Value | INR 2 per share |
Retail Allocation | 35% |
Listing On | NSE, BSE |
MedPlus Health’s Financial Performance
 | FY2019 | FY2020 | FY2021 | H1 FY2022 |
Revenue | 2,285.0 | 2,887.9 | 3,090.8 | 1,890.9 |
Expenses | 2,262.2 | 2,858.5 | 2,995.7 | 1,807.3 |
Net income | 10.5 | (0.5) | 64.1 | 68.2 |
Margin (%) | 0.5 | (0.02) | 2.1 | 3.6 |
MedPlus IPO News
MedPlus Valuations & Margins
FY2019 | FY2020 | FY2021 | |
EPS | 1.10 | 0.20 | 5.88 |
PE ratio | – | – | 132.65 – 135.37 |
RONW (%) | 4.09 | 0.41 | 8.74 |
ROCE (%) | – | 19.87 | 26.08 |
EBITDA (%) | 5.78 | 5.26 | 7.76 |
Debt/Equity | 0.04 | 0.02 | 0.21 |
NAV | – | – | 65.37 |
MedPlus IPO GMP Daily Trend
Date | MedPlus IPO GMP | Kostak | Subject to Sauda |
22 Dec 2021 | INR150 | INR350 | INR2,500 |
21 Dec 2021 | INR150 | INR350 | INR2,500 |
20 Dec 2021 | INR160 | INR350 | INR2,800 |
18 Dec 2021 | INR200 | INR400 | INR3,000 |
17 Dec 2021 | INR220 | INR400 | INR3,000 |
16 Dec 2021 | INR200 | INR380 | INR2,800 |
15 Dec 2021 | INR200 | INR400 | INR3,000 |
14 Dec 2021 | INR250 | INR400 | INR3,200 |
13 Dec 2021 | INR300 | INR420 | INR3,600 |
11 Dec 2021 | INR320 | INR450 | INR3,900 |
10 Dec 2021 | INR300 | INR400 | INR3,700 |
9 Dec 2021 | INR280 | INR400 | INR3,500 |
8 Dec 2021 | INR300 | INR400 | INR3,000 |
MedPlus IPO Subscription – Live Updates
Category | Shares Offered | Day 1 | Day 2 | Day 3 |
QIB | 35,72,550 | 0.06 | 0.09 | 111.90 |
NII | 26,79,414 | 0.16 | 0.50 | 85.33 |
Retail | 62,51,965 | 1.29 | 2.64 | 5.24 |
Employees | 71,225 | 0.76 | 1.73 | 3.05 |
Total | 1,25,75,154 | 0.70 | 1.46 | 52.59 |
MedPlus Health IPO Reviews – Subscribe or Avoid?
Angel One – Subscribe
Anand Rathi –
Antique Stock Broking –
Arihant Capital –
Ashika Research – Not rated
Asit C Mehta –
BP Wealth – Subscribe
Canara Bank Securities – Avoid
Choice Broking – Subscribe
Elite Wealth – Subscribe
GEPL Capital – Subscribe
Hem Securities – Subscribe
ICICIdirect – Subscribe
KR Choksey – Subscribe
Marwadi Financial Services – Subscribe
Motilal Oswal –
Nirmal Bang – Subscribe for long term
Prabhudas Lilladher – Subscribe
Religare Broking –
Samco Securities – Subscribe for long term
SMC Global – 2.5/5
Ventura Securities – Subscribe
MedPlus Health Offer Registrar
KFin Technologies Private Limited
Selenium Tower B,
Plot No- 31 and 32, Financial District,
Nanakramguda, Serilingampally,
Hyderabad, Rangareedi 500 032,
Telangana, India
Phone: +91 40 6716 2222
Email:Â [email protected]
Website:Â www.kfintech.com
MedPlus Health Contact Details
MedPlus Health Services Limited
Municipal No: 11-6-56,
Survey No. 257 & 258/1,
C Block, III Floor,
Opp: Railway Siding (Moosapet),
Kukatpally, Hyderabad 500 037,
Telangana, India;
Phone:Â +91 040 6724 6724;
Email:Â [email protected]
Website: www.medplusindia.com
MedPlus IPO Allotment Status
MedPlus Health IPO allotment is now available on KFin Technologies’ website. Click on this link to get allotment status.
MedPlus IPO Timetable
IPO Opening Date | 13 December 2021 |
IPO Closing Date | 15 December 2021 |
Finalisation of Basis of Allotment | 20 December 2021 |
Initiation of refunds | 21 December 2021 |
Transfer of shares to demat accounts | 22 December 2021 |
Listing Date | 23 December 2021 |
Opening Price on NSE | INR1,040 per share (up 30.65% from IPO price) |
Closing Price on NSE | INR1,120 per share (up 40.7% from IPO price) |
MedPlus IPO FAQs
How many shares in MedPlus IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.
How to apply in MedPlus Health Public Offer?
The best way to apply in MedPlus Health IPO is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is MedPlus IPO GMP today?
MedPlus Health IPO GMP today is INR150 per share.
What is MedPlus IPO kostak rate today?
MedPlus Health IPO kostak rate today is INR350 per application.
What is MedPlus Health Subject to Sauda rate today?
MedPlus Health Subject to Sauda rate today is INR2,500 per application.